Biogen | BIIB - Passifs Courants

Prix De L'Action
186.72
Variation Quotidienne
-2.56 -1.35%
Mensuellement
5.29%
Annuel
51.15%
Q2 Prévisions
180.43




Passifs Courants Changement Date
AbbVie USD 43.29B 3.9B 2025-12
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
ALKERMES USD 543.44M 69.08M 2025-12
Amgen USD 24.96B 534M 2026-03
Bayer EUR 32.58B 3.63B 2025-12
Biogen USD 3B 350.5M 2026-03
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
Incyte USD 1.49B 25.52M 2026-03
Merck USD 28.33B 301M 2025-12
Moderna USD 2.4B 408M 2026-03
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 30.01B 1.66B 2026-03
Sanofi EUR 28.35B 9.32B 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
United Therapeutics USD 560.6M 14.3M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12